Relates to continuing medical education requirements for doctors, nurses and pharmacists; requires three hours of training on the prevention, treatment and mitigation of opiate analgesics and psychotropic drug addiction.
STATE OF NEW YORK
________________________________________________________________________
650
2017-2018 Regular Sessions
IN SENATE
January 4, 2017
___________
Introduced by Sens. KENNEDY, AVELLA, MONTGOMERY -- read twice and
ordered printed, and when printed to be committed to the Committee on
Higher Education
AN ACT to amend the education law, in relation to continuing medical
education for doctors, nurses and pharmacists
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. This act shall be known and may be cited as the "Michael
2 David Israel physician training law".
3 § 2. The education law is amended by adding a new section 6524-a to
4 read as follows:
5 § 6524-a. Mandatory continuing medical education. 1. All physicians,
6 in order to maintain their license in good standing, must complete three
7 hours of continuing medical education on the prescription of opiate
8 analgesics and psychotropic drugs and the risks of addiction in their
9 administration. The classes shall be taught and administered by the
10 office of the professions according to regulations set by the commis-
11 sioner and shall focus on the prevention, treatment and mitigation of
12 such addictions.
13 2. For purposes of this section:
14 a. "opiate analgesics" shall mean the medicines buprenorphine, butor-
15 phanol, codeine, hydrocodone, hydromorphone, levorphanol, meperidine,
16 methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and
17 propoxyphene as well as their brand names, isomers and combinations.
18 b. "psychotropic drugs" shall mean any drug or medicine that affects
19 mental activity, behavior or perception including anti-psychotics, anti-
20 depressants, anti-anxiety drugs or anxiolytics and hypnotics.
21 § 3. The education law is amended by adding a new section 6905-a to
22 read as follows:
23 § 6905-a. Mandatory continuing medical education. 1. All registered
24 professional nurses, in order to maintain their license in good stand-
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD00653-01-7
S. 650 2
1 ing, must complete three hours of continuing medical education on the
2 prescription of opiate analgesics and psychotropic drugs and the risks
3 of addiction in their administration. The classes shall be taught and
4 administered by the office of the professions according to regulations
5 set by the commissioner and shall focus on the prevention, treatment and
6 mitigation of such addictions.
7 2. For purposes of this section:
8 a. "opiate analgesics" shall mean the medicines buprenorphine, butor-
9 phanol, codeine, hydrocodone, hydromorphone, levorphanol, meperidine,
10 methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and
11 propoxyphene as well as their brand names, isomers and combinations.
12 b. "psychotropic drugs" shall mean any drug or medicine that affects
13 mental activity, behavior or perception including anti-psychotics, anti-
14 depressants, anti-anxiety drugs or anxiolytics and hypnotics.
15 § 4. Section 6604-a of the education law is amended by adding a new
16 subdivision 7 to read as follows:
17 7. (a) All dentists, in order to maintain their license in good stand-
18 ing, must complete three hours of continuing medical education on the
19 prescription of opiate analgesics and psychotropic drugs and the risks
20 of addiction in their administration. The classes shall be taught and
21 administered by the office of the professions according to regulations
22 set by the commissioner and shall focus on the prevention, treatment and
23 mitigation of such addictions.
24 (b) For purposes of this section:
25 i. "opiate analgesics" shall mean the medicines buprenorphine, butor-
26 phanol, codeine, hydrocodone, hydromorphone, levorphanol, meperidine,
27 methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and
28 propoxyphene as well as their brand names, isomers and combinations; and
29 ii. "psychotropic drugs" shall mean any drug or medicine that affects
30 mental activity, behavior or perception including antipsychotics, anti-
31 depressants, anti-anxiety drugs or anxiolytics and hypnotics.
32 § 5. This act shall take effect immediately, provided however, the
33 addition, amendment and/or repeal of any rule or regulation necessary
34 for the implementation of this act on its effective date are authorized
35 to be made on or before such effective date.
